Liminal Biosciences Stock Price, News & Analysis

LMNL NASDAQ

Company Description

Liminal Biosciences (NASDAQ: LMNL) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

LMNL stock has declined 100.0% over the past year.

This page provides a comprehensive overview of LMNL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

3.2M

Shares outstanding

Liminal Biosciences (LMNL) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

September 26, 2023

0.00%

LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP

September 19, 2023

0.00%

LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP

September 15, 2023

+0.12%

LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP

September 12, 2023

+0.12%

LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULAR

August 16, 2023

+0.12%

LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LP

August 8, 2023

+0.12%

Liminal BioSciences Reports Second Quarter Financial Results 2023

earnings

Liminal Biosciences has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all LMNL news →

SEC Filings

View All

No SEC filings available for LMNL.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

LMNL Company Profile & Sector Positioning

Liminal Biosciences (LMNL) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.